ALAMYCIN LA 200MG/ML SOLUTION FOR INJECTION

Država: Irska

Jezik: engleski

Izvor: HPRA (Health Products Regulatory Authority)

Aktivni sastojci:

OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)

Dostupno od:

Norbrook Laboratories Limited

ATC koda:

QJ01AA06

INN (International ime):

OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)

Doziranje:

Mg/Ml

Farmaceutski oblik:

Solution for Injection

Tip recepta:

POM

Terapijska grupa:

Bovine, Ovine, Porcine

Područje terapije:

Oxytetracycline

Terapijske indikacije:

Antibacterial

Status autorizacije:

Authorised

Datum autorizacije:

1988-10-01

Svojstava lijeka

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Alamycin LA 200mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance
Oxytetracycline (as Oxytetracycline Dihydrate)
200
mg
Excipient
Sodium Formaldehyde Sulphoxylate
4
mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear amber solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep, pigs and piglets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Oxytetracycline is active against a wide range of Gram-positive and Gram-negative pathogenic bacteria, certain
rickettsia and the larger viruses. Alamycin LA is indicated in the treatment of a wide range of common systemic,
respiratory and local infections caused by or associated with organisms sensitive to oxytetracycline in cattle, sheep and
pigs.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from hepatic or renal damage.
Do not use in animals with known hypersensitivity to Oxytetracycline.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 21/12/2015_
_CRN 7022548_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not dilute Alamycin LA.
If concurrent treatment is administered, use a separate injection site.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
None known.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Although well tolerated, occasionally a slight local reaction of a transient nature has been observed.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
The use of tetracycline during the period of tooth and bo